Non-coding RNAs as drug targets

Masayuki Matsui, David R. Corey

Research output: Contribution to journalArticle

139 Citations (Scopus)

Abstract

Most of the human genome encodes RNAs that do not code for proteins. These non-coding RNAs (ncRNAs) may affect normal gene expression and disease progression, making them a new class of targets for drug discovery. Because their mechanisms of action are often novel, developing drugs to target ncRNAs will involve equally novel challenges. However, many potential problems may already have been solved during the development of technologies to target mRNA. Here, we discuss the growing field of ncRNA — including microRNA, intronic RNA, repetitive RNA and long non-coding RNA — and assess the potential and challenges in their therapeutic exploitation.

Original languageEnglish (US)
JournalNature Reviews Drug Discovery
DOIs
StateAccepted/In press - Jul 22 2016

Fingerprint

Untranslated RNA
RNA
Long Noncoding RNA
Pharmaceutical Preparations
Human Genome
Drug Discovery
MicroRNAs
Disease Progression
Technology
Gene Expression
Messenger RNA
Proteins
Therapeutics

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

Non-coding RNAs as drug targets. / Matsui, Masayuki; Corey, David R.

In: Nature Reviews Drug Discovery, 22.07.2016.

Research output: Contribution to journalArticle

@article{3a412378e48943d389edfb0f5a797cd4,
title = "Non-coding RNAs as drug targets",
abstract = "Most of the human genome encodes RNAs that do not code for proteins. These non-coding RNAs (ncRNAs) may affect normal gene expression and disease progression, making them a new class of targets for drug discovery. Because their mechanisms of action are often novel, developing drugs to target ncRNAs will involve equally novel challenges. However, many potential problems may already have been solved during the development of technologies to target mRNA. Here, we discuss the growing field of ncRNA — including microRNA, intronic RNA, repetitive RNA and long non-coding RNA — and assess the potential and challenges in their therapeutic exploitation.",
author = "Masayuki Matsui and Corey, {David R.}",
year = "2016",
month = "7",
day = "22",
doi = "10.1038/nrd.2016.117",
language = "English (US)",
journal = "Nature Reviews Drug Discovery",
issn = "1474-1776",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Non-coding RNAs as drug targets

AU - Matsui, Masayuki

AU - Corey, David R.

PY - 2016/7/22

Y1 - 2016/7/22

N2 - Most of the human genome encodes RNAs that do not code for proteins. These non-coding RNAs (ncRNAs) may affect normal gene expression and disease progression, making them a new class of targets for drug discovery. Because their mechanisms of action are often novel, developing drugs to target ncRNAs will involve equally novel challenges. However, many potential problems may already have been solved during the development of technologies to target mRNA. Here, we discuss the growing field of ncRNA — including microRNA, intronic RNA, repetitive RNA and long non-coding RNA — and assess the potential and challenges in their therapeutic exploitation.

AB - Most of the human genome encodes RNAs that do not code for proteins. These non-coding RNAs (ncRNAs) may affect normal gene expression and disease progression, making them a new class of targets for drug discovery. Because their mechanisms of action are often novel, developing drugs to target ncRNAs will involve equally novel challenges. However, many potential problems may already have been solved during the development of technologies to target mRNA. Here, we discuss the growing field of ncRNA — including microRNA, intronic RNA, repetitive RNA and long non-coding RNA — and assess the potential and challenges in their therapeutic exploitation.

UR - http://www.scopus.com/inward/record.url?scp=84979222074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979222074&partnerID=8YFLogxK

U2 - 10.1038/nrd.2016.117

DO - 10.1038/nrd.2016.117

M3 - Article

C2 - 27444227

AN - SCOPUS:84979222074

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

SN - 1474-1776

ER -